Dr Agarwals Eye Hospital Ltd
₹5163
+15 (0.29%)
Sun, 25 Oct 2026, 09:10 am
Health Services
Medical/Nursing Services
24.5KDr Agarwals Eye Hospital Ratios
| Particulars | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 18.20 | 15.40 | 138.68 | 42.25 | 46.55 | 20.26 | 14.68 | 10.34 | 13.90 | 10.31 | 2440 | 19.22 | 41.60 | 14.33 | 6.56 | 0 | 14.25 | 11.65 | 31.46 | 34.85 |
| Price to book ratio | 2.16 | 1.84 | 2.19 | 1.35 | 2.40 | 3.60 | 1.79 | 2.08 | 1.81 | 2.47 | 3.91 | 4.80 | 8.04 | 3.75 | 1.60 | 2.69 | 4.39 | 3.80 | 9.28 | 9.09 |
| Price to sales ratio | 0.80 | 0.89 | 0.53 | 0.19 | 0.28 | 0.40 | 0.23 | 0.30 | 0.30 | 0.50 | 0.68 | 0.95 | 1.84 | 1.01 | 0.51 | 1.05 | 1.71 | 1.60 | 4.57 | 4.80 |
| Price to cash flow ratio | 6.31 | 20.28 | 0 | 2.91 | 2.99 | 6.29 | 3.01 | 3.94 | 3.95 | 5.73 | 6.68 | 8.17 | 16.99 | 7.77 | 2.52 | 4.66 | 6.24 | 6.32 | 16.12 | 20.85 |
| Enterprise value | 10.87Cr | 19.85Cr | 41.91Cr | 41.86Cr | 54Cr | 68.64Cr | 48.07Cr | 55.06Cr | 58.3Cr | 83.75Cr | 120Cr | 161Cr | 298Cr | 190Cr | 143Cr | 193Cr | 508Cr | 635Cr | 1693Cr | 2213Cr |
| Enterprise value to EBITDA ratio | 8.39 | 5.23 | 9.86 | 4.36 | 4.72 | 5.17 | 4.06 | 4.31 | 4.56 | 5.49 | 7.53 | 6.84 | 12.19 | 6.33 | 2.98 | 6.14 | 8.62 | 8.28 | 18.19 | 18.28 |
| Debt to equity ratio | 0.36 | 0.48 | 2.26 | 3.11 | 3.14 | 2.62 | 2.18 | 1.82 | 1.47 | 1.13 | 1.33 | 0.78 | 0.52 | 0.52 | 1.07 | 1.24 | 2.47 | 2.05 | 1.71 | 1.59 |
| Return on equity % | 0 | 16.21 | 1.54 | 3.26 | 5.21 | 18.95 | 12.97 | 21.83 | 14.05 | 26.67 | 0.16 | 27.78 | 20.83 | 29.55 | 26.91 | -2.60 | 36.29 | 38.56 | 34.28 | 29.80 |
Dr Agarwals Eye Hospital Ltd Ratios
The Dr Agarwals Eye Hospital Ltd Ratios page provides a complete fundamental analysis of Dr Agarwals Eye Hospital Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Dr Agarwals Eye Hospital Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.
Dr Agarwals Eye Hospital Ltd (NSE: , BSE: 526783) is currently trading at ₹5163, with a market capitalization of ₹2498.6Cr. As a major player in the Health services sector and Medical/Nursing services industry, Dr Agarwals Eye Hospital Ltd remains a key stock for fundamental analysis using Dr Agarwals Eye Hospital Ltd Ratios.
Dr Agarwals Eye Hospital Ltd Ratios: Valuation Overview
Price to Earnings Ratio (P/E)
The Dr Agarwals Eye Hospital Ltd P/E ratio currently stands at 34.85, making it one of the most tracked metrics in Dr Agarwals Eye Hospital Ltd Ratios.
Historically, the Dr Agarwals Eye Hospital Ltd P/E ratio has shown strong fluctuations:
- 2025: 34.85
- 2024: 31.46
- 2023: 11.65
- 2022: 14.25
- 2021: 0
The rising Dr Agarwals Eye Hospital Ltd P/E ratio indicates increasing investor confidence and premium valuation.
Price to Book Ratio (P/B)
The Dr Agarwals Eye Hospital Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 9.09.
Historical P/B trend:
- 2025: 9.09
- 2024: 9.28
- 2023: 3.80
- 2022: 4.39
Dr Agarwals Eye Hospital Ltd is trading at a premium to its book value, indicating strong market confidence.
Price to Sales Ratio (P/S)
The Dr Agarwals Eye Hospital Ltd P/S ratio currently stands at 4.80, an important part of Dr Agarwals Eye Hospital Ltd Ratios for revenue valuation.
Historical P/S ratio:
- 2025: 4.80
- 2024: 4.57
- 2023: 1.60
- 2022: 1.71
The rising Dr Agarwals Eye Hospital Ltd P/S ratio indicates improved revenue valuation by investors.
Dr Agarwals Eye Hospital Ltd Price to Cash Flow Ratio (P/CF)
The Dr Agarwals Eye Hospital Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 20.85.
Historical Dr Agarwals Eye Hospital Ltd Price to Cash Flow Ratio:
- 2025: 20.85
- 2024: 16.12
- 2023: 6.32
- 2022: 6.24
- 2021: 4.66
The rising Dr Agarwals Eye Hospital Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.
Dr Agarwals Eye Hospital Ltd Enterprise Value Ratios
Enterprise Value (EV)
The Dr Agarwals Eye Hospital Ltd EV currently stands at ₹2213Cr, representing the total company valuation including debt.
Historical EV trend:
- 2025: 2213Cr
- 2024: 1693Cr
- 2023: 635Cr
- 2022: 508Cr
Dr Agarwals Eye Hospital Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.
EV/EBITDA Ratio
The Dr Agarwals Eye Hospital Ltd EV/EBITDA ratio is currently 18.28, a key metric in Dr Agarwals Eye Hospital Ltd Ratios to assess valuation relative to earnings.
Historical EV/EBITDA:
- 2025: 18.28
- 2024: 18.19
- 2023: 8.28
- 2022: 8.62
Higher Dr Agarwals Eye Hospital Ltd EV/EBITDA suggests premium valuation.
Dr Agarwals Eye Hospital Ltd Financial Strength Ratios
Debt to Equity Ratio (D/E)
The Dr Agarwals Eye Hospital Ltd D/E ratio is currently 1.59, reflecting leverage and financial stability.
Historical D/E:
- 2025: 1.59
- 2024: 1.71
- 2023: 2.05
- 2022: 2.47
Higher D/E ratio indicates rising financial risk.
Return on Equity (ROE %)
The Dr Agarwals Eye Hospital Ltd ROE currently stands at 29.80%, showing profitability and capital efficiency.
Historical ROE:
- 2025: 29.80
- 2024: 34.28
- 2023: 38.56
- 2022: 36.29
Dr Agarwals Eye Hospital Ltd demonstrates strong profitability and efficient capital utilization.
Dr Agarwals Eye Hospital Ltd Ratios Analysis Summary
The Dr Agarwals Eye Hospital Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Dr Agarwals Eye Hospital Ltd stock is undervalued, fairly valued, or overvalued.
Tracking Dr Agarwals Eye Hospital Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.
